Rui Jiang

Corporate Secretary en JINKO SOLAR CO., LTD. .

41 años

Process Industries

Consumer Services

Electronic Technology

Perfil

Rui Jiang currently works at Cali Biosciences Co. Ltd., as Non-Executive Director from 2021 and Jinko Solar Co., Ltd., as Secretary from 2021.
Mr. Jiang also formerly worked at Bloomage Biotechnology Corp.
Ltd., as Board Secretary, Director & Deputy General Manager from 2019 to 2020.
Mr. Jiang received his graduate degree in 2008 from Renmin University of China.

Cargos activos de Rui Jiang

Empresas	Cargo	Inicio
JINKO SOLAR CO., LTD.	Corporate Secretary	07/01/2021
Cali Biosciences Co. Ltd. Cali Biosciences Co. Ltd. BiotechnologyHealth Technology Cali Biosciences Co. Ltd. operates as a biotechnology company dedicated to the research and development of new drugs for the perioperative space based on drug delivery platforms and other patented technologies. Its product focuses on non-opioid post-operative pain management, anti-inflammatory pain control, anesthesia, and sedation. The company was founded by Dibang Lin and Andrew Xian Chen on March 17, 2021 and is headquartered in Shenzhen, China.	Director/Board Member	17/03/2021

Todos los cargos activos de Rui Jiang

Antiguos cargos conocidos de Rui Jiang.

Empresas	Cargo	Fin
BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED	Director/Board Member	25/12/2020

Ver el detalle de la experiencia de Rui Jiang.

Formación de Rui Jiang.

Renmin University of China

Graduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Rui Jiang.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	2
BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED	Process Industries
JINKO SOLAR CO., LTD.	Electronic Technology

Empresas privadas	1
Cali Biosciences Co. Ltd. Cali Biosciences Co. Ltd. BiotechnologyHealth Technology Cali Biosciences Co. Ltd. operates as a biotechnology company dedicated to the research and development of new drugs for the perioperative space based on drug delivery platforms and other patented technologies. Its product focuses on non-opioid post-operative pain management, anti-inflammatory pain control, anesthesia, and sedation. The company was founded by Dibang Lin and Andrew Xian Chen on March 17, 2021 and is headquartered in Shenzhen, China.	Health Technology